Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2014

View Archived Issues

Bayer presents first-in-human and promising in vivo data for BAY-85-8501

Discovery of novel allosteric GSK-3 inhibitors for the treatment of neurodegenerative diseases

Sanofi and MyoKardia form collaboration to develop treatments for genetic cardiomyopathies

Genzyme product receives orphan designation for Gaucher's disease

Legalon Sil given FDA orphan designation for amatoxin poisoning

BA-321, a selective androgen receptor modulator for treatment of male osteoporosis

Cell Cure Neurosciences shows safety and efficacy of OpRegen in animal studies

Metabolon partners with Metdia for European commercialization of prediabetes tests

Sutro Biopharma and Merck KGaA establish ADC collaboration agreement

Glenmark completes phase IIa study of TRPA1 receptor antagonist

USP7 gene polymorphisms linked to breast cancer susceptibility in Chinese women

World Alzheimer's Day: Research efforts towards early diagnosis and new therapeutic strategies

Research looks into role of betatrophin in human diabetes and its potential as a biomarker

Shionogi discloses novel AMPK activators for diabetes

Avraham Pharmaceuticals raises additional funding to advance ladostigil development

Mochida Pharmaceutical synthesizes new PDE10 inhibitors

Janssen patents novel compounds for HBV infection

Scientists at Bristol-Myers Squibb disclose new agents for cancer

Therabiol divulges new vaccines for HIV infection

Pocket consortium updates on tuberculosis diagnostic device

Zydelig approved in E.U. for chronic lymphocytic leukemia and follicular lymphoma

Fred Hutchinson Cancer Research Center receives grant to run infection epidemiology center

Umecrine Mood reports results from phase I/II trial of UC-1010

Japanese approval of Eylea for myopic choroidal neovascularization

Nuvilex advances Cell-in-a-Box programs for pancreatic cancer and diabetes

Qu Biologics closes private financing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...